Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This multicenter study is being conducted to determine whether infliximab exposure after an
initial infusion is predictive of early clinical response in hospitalized pediatric patients
with severe steroid-refractory UC or IBD-U. This pilot and feasibility study will establish
the infrastructure, demonstrate feasibility, and collect preliminary data to support the full
study.